glp-1 receptors in the brain From metabolism to mind: expanding role of the receptor neurotherapeutics Nature: Dual-active molecules targeting GLP-1R

While reduced appetite is completely normal on GLP-1s, skipping meals entirely is not recommended

While the study was conducted in mice, researchers say the findings raise concerns about how intermittent use could impact human patients

Help us make a difference

This includes adhering to Good Manufacturing Practices (GMP) to guarantee product safety and quality

The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimers disease

[76] Several clinical trials on additional GLP-1-based agents including triple agonists (Retatrutide), [77] oral formation (Orforglipron), [78] and combination therapy (CagriSema) are in the late phase of trials